Ghent, Belgium

Johan T Van Der Eycken

This inventor holds 1 USPTO granted patent. Top assignee: Duphar International Research Bv. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johan T Van Der Eycken. Retrieved from https://idiyas.com/inventor/johan-t-van-der-eycken

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Johan T Van Der Eycken

Introduction

Johan T Van Der Eycken is a notable inventor based in Gent, Belgium. He has made significant contributions to the field of chemistry, particularly in the development of new compounds with potential therapeutic applications. His work focuses on di- and tetrahydroisoquinoline derivatives, which exhibit interesting cytostatic properties.

Latest Patents

Johan holds 1 patent for his invention titled "Di- and tetrahydroisoquinoline derivatives." This patent relates to new compounds that have shown promising cytostatic properties. The invention also covers the preparation of these new compounds and their use in compositions as cytostatically active substances.

Career Highlights

Johan is associated with Duphar International Research Bv, where he continues to explore innovative solutions in the pharmaceutical field. His research has the potential to contribute significantly to the development of new treatments for various diseases.

Collaborations

Some of Johan's notable coworkers include Maurits E Vandewalle and Ineke Van Wijngaarden. Their collaborative efforts enhance the research environment and foster innovation within their projects.

Conclusion

Johan T Van Der Eycken's work exemplifies the spirit of innovation in the field of chemistry. His contributions through patents and collaborations highlight the importance of research in developing new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…